Viridian Therapeutics, Inc.\DE
Viridian Therapeutics, Inc.\DE (VRDN) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 62 transactions totaling $84.9M, demonstrating a bullish sentiment with $61.3M in net insider flow. The most recent transaction on Oct 23, 2025 involved a purchase of 454,545 shares valued at $10.0M.
VRDN Insider Activity Summary
Who Is Buying VRDN Stock?
No significant insider buying has been recorded for VRDN in the recent period.
Who Is Selling VRDN Stock?
No significant insider selling has been recorded for VRDN in the recent period.
Is Viridian Therapeutics, Inc.\DE Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VRDN is bullish with an Insider Alignment Score of 86/100 and a net flow of $61.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VRDN Frequently Asked Questions
Understanding VRDN Insider Activity
Insider trading at Viridian Therapeutics, Inc.\DE (VRDN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading VRDN stock, having executed 62 transactions in the past 90 days. The most active insider is Healthcare Fund II L.p. Fairmount (Executive), who has made 4 transactions totaling $40.0M.
Related Tools
Track Viridian Therapeutics, Inc.\DE Insider Activity
Get notified when executives and directors at VRDN file new Form 4 transactions